Solitary retinal capillary hemangioma: Lack of genetic evidence for von Hippel-Lindau disease

Ophthalmic Genetics

Volumn 23, Issue 1, 2002, Pages 21-27

  Singh, Arun D ^a   Ahmad, N Nina ^a   Shields, Carol L ^a   Shields, Jerry A ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

Eye; Genetic testing; Retinal capillary hemangioma; Tumor; Von Hippel Lindau disease

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAPILLARY HEMANGIOMA; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GEL ELECTROPHORESIS; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; GENETIC SCREENING; HUMAN; PRIORITY JOURNAL; PROBABILITY; RETINA CAPILLARY; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; HEMANGIOMA, CAPILLARY; HIPPEL-LINDAU DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETINAL NEOPLASMS; RISK FACTORS;

EID: 0036205412     PISSN: 13816810     EISSN: None     Source Type: Journal    
DOI: 10.1076/opge.23.1.21.2201     Document Type: Article

References (22)

1. Von Hippel-Lindau disease
2. Clinical features and natural history of von Hippel-Lindau disease
3. Von Hippel-Lindau disease: A genetic study
4. Von Hippel-Lindau disease: Genetic, clinical and imaging features
5. Von Hippel-Lindau disease in a large British family: Clinicopathological features and recommendations for screening and follow-up
6. Identification of the von Hippel-Lindau disease tumor suppressor gene
7. Improved detections of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
8. Germline mutations in the von Hippel-Lindau disease (VHL) gene in the families from North America, Europe, and Japan
9. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlation with phenotype
10. Clinical characteristics of ocular angiomatosis in Hippel-Lindau disease and correlation with germline mutation
11. Solitary retinal capillary hemangioma: Hereditary (von Hippel-Lindau disease) or non hereditary?
12. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent
13. National Advisory Council for Human Genome Research. Statement on use of DNA testing for presymptomatic identification of cancer risk
14. Conformation sensitive gel electrophoresis for rapid detection of single-base differences in double stranded PCR products and DNA fragments: Evidence of solvent induced bends in DNA heteroduplexes
15. Three new point mutations in type II collagen (COL2A1) and identification of fourth family with the COL2A1 Arg519→ Cys base substitution using conformation sensitive gel electrophoresis
16. VHL tumor suppressor gene mutations in renal carcinogenesis
17. Identification of promoter of the human von Hippel-Lindau disease tumor suppressor gene
18. A clinical and molecular genetic analysis of solitary ocular angioma
19. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene
20. Mosaicism in von Hippel-Lindau disease: Lessons from kindreds with germline mutations identified in offspring with mosaic parents
21. Risk of multisystem disease in isolated ocular angioma (haemangioblastoma)